Literature DB >> 19871438

CHEMICAL STUDIES ON BACTERIAL AGGLUTINATION : VII. A QUANTITATIVE STUDY OF THE TYPE SPECIFIC AND GROUP SPECIFIC ANTIBODIES IN ANTIMENINGOCOCCAL SERA OF VARIOUS SPECIES AND THEIR RELATION TO MOUSE PROTECTION.

E A Kabat1, C P Miller, H Kaiser, A Z Foster.   

Abstract

1. The quantitative method for the estimation of agglutinins has been applied to antimeningococcal horse, rabbit, and chicken sera and to the sera of humans convalescing from meningococcus meningitis. The type-specific and group-specific agglutinin N can be measured, using homologous and heterologous suspensions of meningococci. 2. Type I horse, rabbit, and chicken antimeningococcal sera contain considerable amounts of antibody which cannot be removed either by Type II meningococcus suspension or by preparations of the Type I specific polysaccharide. This residual type-specific antibody has marked potency in protecting mice against subsequent infection with meningococci. 3. Most human convalescent sera contain group-specific antibody. Small amounts of protective antibody and of antipolysaccharide are also formed. 4. Type I antisera absorbed with Type I polysaccharide and with Type II meningococci could be used as a guide in the purification of this new antigen.

Entities:  

Year:  1945        PMID: 19871438      PMCID: PMC2135534          DOI: 10.1084/jem.81.1.1

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  10 in total

1.  INVESTIGATIONS OF MENINGOCOCCAL INFECTION. II. IMMUNOLOGICAL ASPECTS.

Authors:  L Thomas; H W Smith; J H Dingle
Journal:  J Clin Invest       Date:  1943-05       Impact factor: 14.808

2.  THE IMMUNE RESPONSE OF HUMAN BEINGS TO BRIEF INFECTIONS WITH PNEUMOCOCCUS.

Authors:  M Heidelberger; D G Anderson
Journal:  J Clin Invest       Date:  1944-09       Impact factor: 14.808

3.  EXPERIMENTAL MENINGOCOCCAL INFECTION IN MICE.

Authors:  C P Miller
Journal:  Science       Date:  1933-10-13       Impact factor: 47.728

4.  QUANTITATIVE MICRO-ESTIMATION OF ANTIBODIES IN THE SERA OF MAN AND OTHER ANIMALS.

Authors:  M Heidelberger; C F Macpherson
Journal:  Science       Date:  1943-04-30       Impact factor: 47.728

5.  CHEMICAL STUDIES ON BACTERIAL AGGLUTINATION : III. A REACTION MECHANISM AND A QUANTITATIVE THEORY.

Authors:  M Heidelberger; E A Kabat
Journal:  J Exp Med       Date:  1937-05-31       Impact factor: 14.307

6.  CHEMICAL STUDIES ON BACTERIAL AGGLUTINATION : VI. THE AGGLUTININ CONTENT OF ANTISERA TO HEMOLYTIC STREPTOCOCCI.

Authors:  S D Henriksen; M Heidelberger
Journal:  J Exp Med       Date:  1941-07-31       Impact factor: 14.307

7.  QUANTITATIVE CHEMICAL STUDIES ON COMPLEMENT OR ALEXIN : IV. ADDITION OF HUMAN COMPLEMENT TO SPECIFIC PRECIPITATES.

Authors:  M Heidelberger; M Mayer
Journal:  J Exp Med       Date:  1942-03-01       Impact factor: 14.307

8.  PREPARATION OF THE TYPE-SPECIFIC POLYSACCHARIDE OF THE TYPE I MENINGOCOCCUS AND A STUDY OF ITS EFFECTIVENESS AS AN ANTIGEN IN HUMAN BEINGS.

Authors:  E A Kabat; H Kaiser; H Sikorski
Journal:  J Exp Med       Date:  1944-10-01       Impact factor: 14.307

9.  THE PRECIPITIN REACTION BETWEEN TYPE III PNEUMOCOCCUS POLYSACCHARIDE AND HOMOLOGOUS ANTIBODY : II. CONDITIONS FOR QUANTITATIVE PRECIPITATION OF ANTIBODY IN HORSE SERA.

Authors:  M Heidelberger; F E Kendall
Journal:  J Exp Med       Date:  1935-03-31       Impact factor: 14.307

10.  STUDIES ON MENINGOCOCCUS INFECTION : VIII. THE TYPE I SPECIFIC SUBSTANCE.

Authors:  H W Scherp; G Rake
Journal:  J Exp Med       Date:  1935-05-31       Impact factor: 14.307

  10 in total
  5 in total

1.  Development and characterization of an anti-idiotype antibody to the capsular polysaccharide of Neisseria meningitidis serogroup C.

Authors:  M A Westerink; A A Campagnari; M A Wirth; M A Apicella
Journal:  Infect Immun       Date:  1988-05       Impact factor: 3.441

Review 2.  Anti-idiotypic antibodies as vaccines against carbohydrate antigens.

Authors:  M A Westerink; M A Apicella
Journal:  Springer Semin Immunopathol       Date:  1993

3.  Human immunity to the meningococcus. II. Development of natural immunity.

Authors:  I Goldschneider; E C Gotschlich; M S Artenstein
Journal:  J Exp Med       Date:  1969-06-01       Impact factor: 14.307

4.  Human immunity to the meningococcus. IV. Immunogenicity of group A and group C meningococcal polysaccharides in human volunteers.

Authors:  E C Gotschlich; I Goldschneider; M S Artenstein
Journal:  J Exp Med       Date:  1969-06-01       Impact factor: 14.307

5.  Human immunity to the meningococcus. I. The role of humoral antibodies.

Authors:  I Goldschneider; E C Gotschlich; M S Artenstein
Journal:  J Exp Med       Date:  1969-06-01       Impact factor: 14.307

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.